Search results
Results from the WOW.Com Content Network
Endo Pharmaceuticals Holdings was created as a result of a $277 million management buyout of the division from DuPont Merck in 1997, led by Carol Ammon. [6] Through the merger with Algos, it changed name again to Endo Pharmaceuticals Holdings Inc. and began trading as a public company. [9]
Endo will ask a U.S. bankruptcy judge to approve the sale and allow the company to emerge from bankruptcy at a March 19 court hearing, the DOJ added. Drugmaker Endo reaches $465 million bankruptcy ...
The pharmaceutical company said the following precautionary measures should be taken if you have any of the recalled Clonazepam: Distributors and retailers should stop dispensing the recalled product.
Endo Pharmaceuticals Holdings (NAS: ENDP) reported earnings on May 1. Here are the numbers you need to know. The 10-second takeaway For the quarter ended March 31 (Q1), Endo Pharmaceuticals ...
From a former name: This is a redirect from a former name or working title of the target topic to the new name that resulted from a name change.
There's no foolproof way to know the future for Endo Pharmaceuticals Holdings (NAS: ENDP) or any other company. However, certain clues may help you see potential stumbles before they happen -- and ...
The Endo Pharmaceuticals Building, also known as "Endo Laboratories", is a pharmaceutical plant designed by architect Paul Rudolph in 1962 in Garden City, New York, in the receding farmlands of Long Island. The "castle-like structure" was built to house the Endo Pharmaceuticals research, manufacturing and administration facilities.
Endo Pharmaceuticals (NAS: ENDP) beat estimates by $0.07 last quarter and investors are hoping it can beat them again. The company will unveil its latest earnings on Friday, Feb. 24. Endo ...